orantinib has been researched along with hesperadin in 1 studies
Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (hesperadin) | Trials (hesperadin) | Recent Studies (post-2010) (hesperadin) |
---|---|---|---|---|---|
110 | 19 | 36 | 58 | 0 | 33 |
Protein | Taxonomy | orantinib (IC50) | hesperadin (IC50) |
---|---|---|---|
Aurora kinase A | Homo sapiens (human) | 0.011 | |
Glucose transporter | Leishmania mexicana | 1.114 | |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 0.78 | |
Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 1.344 | |
Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 1.434 | |
Maternal embryonic leucine zipper kinase | Homo sapiens (human) | 0.225 | |
Aurora kinase B-A | Xenopus laevis (African clawed frog) | 0.003 | |
Aurora kinase B | Homo sapiens (human) | 0.2006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatt, HG; Borisa, AC | 1 |
1 review(s) available for orantinib and hesperadin
Article | Year |
---|---|
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Cell Proliferation; Clinical Trials as Topic; Humans; Molecular Structure; Protein Kinase Inhibitors; Small Molecule Libraries | 2017 |